Fighting the epidemic of pediatric metabolic dysfunction-associated steatotic liver disease: Role of non-invasive diagnostics and early pharmacological intervention

doi:10.4254/wjh.v18.i1.111211

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-2)

Sum=3

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=1

Jan 27, 2026 (publication date) through Jan 27, 2026

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Hepatol. Jan 27, 2026; 18(1): 111211
Published online Jan 27, 2026. doi: 10.4254/wjh.v18.i1.111211

Open in New Tab Full Size Figure Download Figure

Figure 1 Proposed algorithm for diagnosis and management of pediatric metabolic dysfunction-associated steatotic liver disease legend. ALT: Alanine aminotransferase; BMI: Body mass index; MASLD: Metabolic dysfunction-associated steatotic liver disease; HDL: High density lipoprotein; A1AT: Alpha 1 antitrypsin; DILI: Drug induced liver injury; IEM: Inborn error of metabolism; LFT: Liver function test; VCTE: Vibration-controlled transient elastography; CAP: Controlled attenuation parameter.

Citation: Ng NBH, Sng AA, Huang JG. Fighting the epidemic of pediatric metabolic dysfunction-associated steatotic liver disease: Role of non-invasive diagnostics and early pharmacological intervention. World J Hepatol 2026; 18(1): 111211
URL: https://www.wjgnet.com/1948-5182/full/v18/i1/111211.htm
DOI: https://dx.doi.org/10.4254/wjh.v18.i1.111211